These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3156649)

  • 1. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
    Schwartz J; Velly J
    Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]nitrendipine binding in the guinea pig left ventricle: effects of calcium and lanthanum.
    Fawzi AB; McNeill JH
    Eur J Pharmacol; 1984 Sep; 104(3-4):357-62. PubMed ID: 6437849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
    Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
    Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
    Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
    J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats.
    Ehlert FJ; Itoga E; Roeske WR; Yamamura HI
    Biochem Biophys Res Commun; 1982 Feb; 104(3):937-43. PubMed ID: 7073736
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.
    Sarmiento JG; Janis RA; Katz AM; Triggle DJ
    Biochem Pharmacol; 1984 Oct; 33(20):3119-23. PubMed ID: 6487362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites.
    Quirion R; Lafaille F; Nair NP
    J Pharm Pharmacol; 1985 Jun; 37(6):437-40. PubMed ID: 2410588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of [3H]nitrendipine binding to cardiac and cerebral cortex membranes by amiodarone.
    Nokin P; Clinet M; Swillens S; Delisée C; Meysmans L; Chatelain P
    J Cardiovasc Pharmacol; 1986; 8(5):1051-7. PubMed ID: 2429079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P; Ferry D; Lübbecke F; Glossman H
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle.
    Fosset M; Jaimovich E; Delpont E; Lazdunski M
    Eur J Pharmacol; 1982 Dec; 86(1):141-2. PubMed ID: 6297924
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of temperature and allosteric modulators on [3H] nitrendipine binding: methods for detecting potential Ca2+ channel blockers.
    Holck M; Fischli W; Hengartner U
    J Recept Res; 1984; 4(1-6):557-69. PubMed ID: 6084712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of some cyclohexylaralkylamines related to perhexiline on sodium influx, binding of [3H]batrachotoxinin A 20-alpha-benzoate and [3H]nitrendipine and on guinea pig left atria contractions.
    Grima M; Velly J; Decker N; Marciniak G; Schwartz J
    Eur J Pharmacol; 1988 Mar; 147(2):173-85. PubMed ID: 3366174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by suloctidil of [3H] nitrendipine binding to cerebral cortex membranes.
    Chatelain P; Demol D; Roba J
    Biochem Pharmacol; 1984 Apr; 33(7):1099-103. PubMed ID: 6324812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.